News
Two NIH Technology Transfer experts will be speaking at the Biotechnology Innovation Organization 2025 International Convention taking place in Boston, June 16-19, 2025, with pre-conference sessions taking place June 14-15. Steve Ferguson, Special Advisor at the NIH Office of Technology Transfer
In the United States, one in four cancer deaths occur from lung cancer, however, there is a lack of lung cancer screenings and analysis available quickly and at a low cost. Scientists from the National Cancer Institute’s (NCI) Laboratory of Human Carcinogenesis have proven a unique, non-invasive
The National Cancer Institute’s (NCI) Drug Synthesis and Chemistry Branch created a potential therapeutic for various types of cancers including colon cancer and leukemia by synthesizing a fluorinated cytidine. They showed that incorporating a fluorine atom into the chemical structure of cytidine
Register for your spot at the National Cancer Institute (NCI) and Frederick National Lab’s (FNL) 2021 Technology Showcase. This event provides potential partners the opportunity to attend presentations on federal technologies ready for commercialization and/or collaboration, watch panel sessions